AMSTERDAM MOLECULAR THERAPEUTICS (AMT) BV - Netherlands 

Ranking results:

Past rankings:

2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2007
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 0 3.308.154 1.092.012 1
2010 0 6.000.000 502.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
DIGNA BIOTECH SL1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
FAUN STIFTUNG NURNBERG1
FONDATION DE COOPERATION SCIENTIFIQUE VOIR ET ENTENDRE1
FONDAZIONE TELETHON1
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH1
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
JOHANNES GUTENBERG UNIVERSITAET MAINZ1
MASSACHUSETTS EYE AND EAR INFIRMARY1
MEDICAL RESEARCH COUNCIL1
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH1
SERVICIO MADRILENO DE SALUD1
STOCKHOLMS LAENS LANDSTING1
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA CORP1
UNIVERSIDAD DE NAVARRA1
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI1

Constancy:

Total number of partners: 18
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 18
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2011-01-01Augmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria AIPGENEparticipant3.308.1547
2010-02-01"Fighting blindness of Usher syndrome: diagnosis, pathogenesis and retinal treatment (TreatRetUsher)" TREATRUSHparticipant6.000.00013

Alias institution names:

  • AMSTERDAM MOLECULAR THERAPEUTICS BV